African Applied Chemical (Pty) Ltd is a bio-technology company that specialises in the manufacture of a proprietary slow release fibres (Bi-KoTM). These fibres are made mainly from polypropylene copolymer. The fibres are specially engineered to store a high amount of liquid within their matrix and slowly release small amounts over a long period of time.

This technology is aimed at slowly releasing high value actives in order to prolong their residual effectiveness and reduce the overall cost of their use in practical applications. 

CapeBio Technologies intends to develop a state-of-the-art AI platform to mine metagenomic data for novel antimicrobial peptide genes. This is a machine-learning and data-science-driven application that allows for better and novel detection of medically important genes that can be used to fight diseases such as cancer and tuberculosis.

Fluorobiotech was founded during the global pandemic, in response to the urgent need for accessible and affordable biotechnology solutions. The company commits itself to bridging this gap by pioneering affordable, cutting-edge biotechnology solutions tailored to emerging markets.

Fluorobiotech offers a self-prep technology designed to burst cells open automatically without mechanical disruption or added chemicals. This genetic modification enables rapid, efficient protein release, simplifying the protein extraction process, reducing costs, and improving repeatability for protein production.

Immobazyme is a South African biotechnology spin-out company of Stellenbosch University that utilises precision fermentation to produce high-value active protein ingredients. Their mission is to catalyse the future of global innovation with precision fermentation. By creating the most desirable and accessible recombinant proteins, they aim to enable businesses to perfect their products and unlock the full potential of their process development.